NCT07081932View on ClinicalTrials.gov

A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

September 27, 2025

Study Completion Date

October 8, 2025

Conditions
Healthy
Interventions
DRUG

Nerandomilast

Nerandomilast

DRUG

Bosentan

Bosentan

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY